Gw. Edelson et al., HYPERCALCEMIA ASSOCIATED WITH WEGENER GRANULOMATOSIS AND HYPERPARATHYROIDISM - ETIOLOGY AND MANAGEMENT, American journal of nephrology, 13(4), 1993, pp. 275-277
We report a case of hypercalcemia in a patient with coexisting hyperpa
rathyroidism and Wegener's granulomatosis. Parathyroidectomy with remo
val of an adenoma resulted in a low parathyroid hormone level but high
calcitriol levels and hypercalcemia persisted. In various granulomato
us diseases, hypercalcemia has been shown to be the result of overprod
uction of 1,25-dihydroxyvitamin D by disease-activated macrophages. Ch
loroquine has been demonstrated to effectively reduce the extrarenal s
ynthesis of 1,25-dihydroxy-vitamin D and serum calcium concentration i
n hypercalcemic patients with sarcoidosis. Hypothesizing that a simila
r mechanism would explain hypercalcemia in Wegener's granulomatosis as
well, a therapeutic trial of chloroquine was initiated. The patient r
esponded to chloroquine 500 mg twice daily with significant decreases
in serum 1,25-dihydroxyvitamin D and calcium levels. This report exten
ds previous observations of hypercalcemia associated with other granul
omatous diseases to Wegener's granulomatosis and demonstrates an effec
tive reduction of serum calcitriol and calcium levels in response to c
hloroquine therapy.